Printer Friendly

TORONTO MARATHON: NOVOPHARM PRESIDENT SETS THE PACE AT NOVOPHARM 10K RUN

TORONTO MARATHON: NOVOPHARM PRESIDENT SETS THE PACE AT NOVOPHARM 10K RUN
 TORONTO, Oct. 2 /CNW/ - Leading off the runners of the Novopharm 10K Run, part of the Shoppers Drug Mart Toronto Marathon, will be Leslie Dan, the company's president. The 63-year-old Dan will set the pace for the 30-member Novopharm running club.
 Novopharm is also sponsor of Carole Rouillard, winner of last year's Toronto Marathon, the Canadian Champion for the 10,000 meter, and a member of the Canadian Olympic Team.
 Starting time for the 10K is 8:00 am, Sunday, October 4. The race begins in front of the ROM.
 For further information: Andrea Dan, Novopharm Ltd., (416) 291-8876
 -0- 10/02/92


CO: NOVOPHARM LTD. ST: -- c0211 -- X075 10/02/92
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 2, 1992
Words:123
Previous Article:TORONTO, Oct. 2 /CNW/ - Toronto Dominion Bank announced the following rate increases, effective October 2, 1992.
Next Article:NORTHERN TELECOM ANNOUNCES DEBT OFFERING


Related Articles
NOVOPHARM LTD. TO ACQUIRE GRANUTEC INC.
NOVOPHARM LTD. TO ACQUIRE GRANUTEC INC.
NOVOPHARM LIMITED ACQUIRES GRANUTEC INC.
DEPRENYL RESEARCH LIMITED AND NOVOPHARM LIMITED ANNOUNCE STRATEGIC ALLIANCE
WARRICK PHARMACEUTICALS AND NOVOPHARM USA EXTEND AGREEMENT ON GENERIC DRUG PRODUCTS
NOVOPHARM WINS RIGHT TO MAKE GLAXO WELLCOME'S ZANTAC; RULING ENDS SIX-YEAR BATTLE WITH DRUG GIANT TO MAKE GENERIC ZANTAC
NOVOPHARM PLANS TO PRODUCE GENERIC ZANTAC IN DECEMBER DESPITE GLAXO WELLCOME'S PATENT APPEAL
Novopharm USA's Agreement with Glaxo Wellcome Puts A Generic Version of Zantac(R) on Market More Than Two Weeks Early
Dr. Rafick G. Henein Named President and CEO Of IVAX Subsidiary Zenith Goldline Pharmaceuticals
Novopharm USA Inc. Files Suit in North Carolina Court To Have Apotex Ranitidine Patent Declared Invalid

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters